SCHEMBL1699197

SCHEMBL1699197

CCCCOC(=O)Nc1ccc(O)cc1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 11/20 0.70
RAB9A P51151 10/20 0.70
NPC1 O15118 9/20 0.70
HPGD P15428 7/20 0.70
MAPT P10636 4/20 0.70
ALDH1A1 P00352 4/20 0.70
MAPK1 P28482 3/20 0.70
KDM4E B2RXH2 2/20 0.70
CASP1 P29466 1/20 0.70
MCL1 Q07820 1/20 0.70
L3MBTL1 Q9Y468 1/20 0.70
KMT2A Q03164 3/20 0.62
TP53 P04637 1/20 0.62
NFKB1 P19838 1/20 0.62
NFKB2 Q00653 1/20 0.62
RELA Q04206 1/20 0.62
CYP1A2 P05177 4/20 0.61
CYP2C19 P33261 4/20 0.61
CYP2C9 P11712 2/20 0.61
LMNA P02545 3/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20302856 0.95 RAB9A (0.64) SMN1; SMN2RAB9ANPC1HPGDMAPT
SCHEMBL7564852 0.93 RAB9A (0.79) SMN1; SMN2RAB9ANPC1HPGDMAPT
SCHEMBL9126319 0.93 SMN1; SMN2 (0.70) SMN1; SMN2RAB9ANPC1HPGDMAPT
SCHEMBL7201367 0.90 NPC1 (0.59) SMN1; SMN2RAB9ANPC1HPGDMAPT
SCHEMBL9126064 0.90 SMN1; SMN2 (0.59) SMN1; SMN2RAB9ANPC1HPGDMAPT
SCHEMBL7195879 0.90 NPC1 (0.59) SMN1; SMN2RAB9ANPC1HPGDMAPT
SCHEMBL9124310 0.90 NPC1 (0.58) SMN1; SMN2RAB9ANPC1HPGDMAPT
SCHEMBL7197815 0.90 NPC1 (0.58) SMN1; SMN2RAB9ANPC1HPGDMAPT
SCHEMBL13387589 0.88 RAB9A (0.72) SMN1; SMN2RAB9ANPC1HPGDMAPT
SCHEMBL10361283 0.88 NPC1 (0.54) SMN1; SMN2RAB9ANPC1HPGDMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2585462-A1 FUSED HETEROCYCLIC COMPOUNDS AS PHOSPHODIESTERASES (PDES) INHIBITORS Takeda Pharmaceutical Company Limited (JP) 2013-05-01 EP disclosed
WO-2011163355-A1 FUSED HETEROCYCLIC COMPOUNDS AS PHOSPHODIESTERASES (PDES) INHIBITORS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-12-29 WO disclosed
EP-0880502-A1 AMINOHETEROCYCLIC DERIVATIVES AS ANTITHROMBOTIC OR ANTICOAGULANT AGENTS ZENECA LIMITED (GB) 1998-12-02 EP disclosed
WO-1997028129-A1 AMINOHETEROCYCLIC DERIVATIVES AS ANTITHROMBOTIC OR ANTICOAGULANT AGENTS ZENECA LIMITED (GB) 1997-08-07 WO disclosed